Dr. Cristina Oliva is a board-certified medical oncologist with over 20 years of international experience in oncology drug development. Her career encompasses senior leadership roles within global pharmaceutical companies, biotechnology firms, and Clinical Research Organizations, where she has successfully advanced numerous oncology and onco-haematology compounds from early clinical stages through to regulatory approval and global market authorization. Cristina has held prominent positions including Vice President and Head of the Oncology Center of Excellence at IQVIA, Chief Medical Officer at Nordic Nanovector, and senior clinical development roles at Shionogi, Takeda Pharmaceuticals, GlaxoSmithKline, and Eli Lilly. Most recently, she served as Chief Medical Officer at BerGenBio, where she was responsible for leading all clinical development activities. She obtained her medical degree and oncology board certification from the University of Genoa in Italy, followed by a Doctorate in Public Health from Kingston University in London.